Transplant clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 12-17
The study's aim is to test a tailored telemetric intervention to reduce rejection incidence by improving medication adherence in a group of adolescent liver transplant recipients identified as nonadherent by a marker (the Medication Level Variability Index, MLVI).
San Francisco, California and other locations